The Independent |
Novartis asthma pill shows promise in small trial
Reuters LONDON The first new asthma pill in decades has produced promising results in a small clinical trial, potentially paving the way for another treatment option for patients by the end of the decade. Fevipiprant, which is being developed by Novartis ... Asthma pill 'promising' for people with severe symptoms Asthma pill could prove 'game changer' for people with severe symptoms Asthma pill could reduce symptoms in severe sufferers |
Novartis asthma pill shows promise in small trial - Reuters
Read More
0 Response to "Novartis asthma pill shows promise in small trial - Reuters"
Post a Comment